Last reviewed · How we verify
NCT02869074: PCM-EVW-ES
Molecular and Clinical Profile of Von Willebrand Disease in Spain
trial testing VWF gene analysis in Von Willebrand Disease in 790 participants. Completed in 25 September 2021.
25 September 2021
Quick facts
| Lead sponsor | Spanish Society of Thrombosis and Haemostasis |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 790 |
| Start date | 3 October 2017 |
| Primary completion | 25 September 2021 |
| Estimated completion | 25 September 2021 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- VWF gene analysis
Conditions studied
- Von Willebrand Disease — all drugs for Von Willebrand Disease →
Sponsor
Spanish Society of Thrombosis and Haemostasis
Who can join
Adults 2 to 80, any sex, with Von Willebrand Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present Project is a third phase of the previous PCM-EVW-ES Project (Batlle et al. Thromb \& Haemost 2015) with the aim of its extension, further analysis with an innovation development in the field of von Willebrand disease (VWD) based in the newer recently available methodologies. The aim of this project is to help the physician in a more uniform characterization and therapy of VWD in clinical practice, at an international level. A reduction of the expenses in the diagnosis process by using the new methodologies is pursued.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort.
Borràs N, Garcia-Martínez I, Batlle J, Pérez-Rodríguez A, et al · · 2020 · cited 4× · PMID 32135566 · DOI 10.1055/s-0040-1702227
Verify or expand the search:
- PubMed search for NCT02869074
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Von Willebrand Disease
Currently open trials in the same condition.
- NCT02932618 — A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Diseas · Phase 3 · recruiting
Other Spanish Society of Thrombosis and Haemostasis trials
Trials by the same sponsor.
- NCT03006965 — Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT® · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02869074 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Spanish Society of Thrombosis and Haemostasis
- Last refreshed: 12 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02869074.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing